Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Peptimmune Inc.

www.peptimmune.com

Latest From F2G Ltd.

Flexible 'Menu' Of Antibacterial Development Options Suggested By US FDA Panel

FDA should consider allowing sponsors in challenging area of single species antibacterials more flexibility in study designs, advisory committee suggests, despite disagreement over approaches such as animal models and non-inferiority trials.

Infectious Diseases Advisory Committees

Antibacterial Development: Industry Cautious About Role Of Animal Models

Payers and prescribers, not just the US FDA, need to understand the basis of approval, John Rex says.

Research & Development Drug Approval Standards

Antibiotic Development: US FDA Needs Draft Guidance On QIDP Designation, GAO Says

Sponsors lack comprehensive advice on how to access benefits of GAIN legislation's incentives, which include the opportunity for fast track designation, priority review designation and five years of market exclusivity, government watchdog says.

Infectious Diseases Regulation

Execs On The Move, August 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Peptimmune Inc.
  • Senior Management
  • Eric Zanelli, PhD, VP, Research
  • Contact Info
  • Peptimmune Inc.
    Phone: (617) 715-8000
    64 Sidney St., Ste. 380
    Cambridge, MA 02139
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register